# EDGAR Filing Document

**Accession Number:** 0001756064
**File Stem:** 0001493152-26-023347
**Filing Date:** 2026-5
**Character Count:** 110382
**Document Hash:** 7b0fd35e51f09de5402f556e26759b9a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-023347.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001493152-26-023347

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 64

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Our Bond, Inc.
- **CENTRAL INDEX KEY:** 0001756064
- **STANDARD INDUSTRIAL CLASSIFICATION:** COMMUNICATION SERVICES, NEC [4899]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 831751618
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43087
- **FILM NUMBER:** 26982382

**BUSINESS ADDRESS:**
- **STREET 1:** 292 NEWBURY STREET, NO. 485
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02115
- **BUSINESS PHONE:** 617-648-9100

**MAIL ADDRESS:**
- **STREET 1:** 85 BROAD
- **STREET 2:** 17TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10004

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TG-17, Inc.
- **DATE OF NAME CHANGE:** 20181016

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

(Mark One)

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2026

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from________ to ___________

Commission File Number: **001-43087**

**<u>Our Bond Inc.</u>**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Nevada** | **83-1751618** |
| (State or other jurisdiction of<br> incorporation or organization) | (I.R.S. Employer<br> Identification No.) |

---

**<u>85 Broad Street</u>** **<u>, 17<sup>TH</sup> Floor</u><u>, New York</u><u>, NY</u><u>10004</u>**

(Address of principal executive offices) (Zip Code)

**1-888-567-6234**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which**<br> **registered** |
| Common Stock par value $0.0001 | OBAI | Nasdaq Capital Market |

---

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Â§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of May 14, 2026, the number of shares outstanding of the issuer's common stock was 24,462,071.

**OUR BOND INC.**

**INDEX TO FORM 10-Q**

---

| | | |
|:---|:---|:---|
|  |  | **Page** |
| **PART I - FINANCIAL INFORMATION** | **PART I - FINANCIAL INFORMATION** |  |
| **Item 1.** | **[Financial Statements](#a_002)** | 1 |
|  | [Condensed Consolidated Balance Sheets as of March 31, 2026 (Unaudited) and December 31, 2025](#a_003) | 1 |
|  | [Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2026 and 2025 (Unaudited)](#a_004) | 2 |
|  | [Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2026 and 2025 (Unaudited)](#a_005) | 3 |
|  | [Condensed Consolidated Statements of Stockholders' Equity for the Three Months Ended March 31, 2026 and 2025 (Unaudited)](#a_006) | 4 |
|  | [Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025 (Unaudited)](#a_007) | 5 |
|  | [Notes to the Unaudited Condensed Consolidated Financial Statements](#a_008) | 6 |
| **Item 2.** | **[Management's Discussion and Analysis of Financial Condition and Results of Operations](#a_009)** | 17 |
| **Item 3.** | **[Quantitative and Qualitative Disclosures About Market Risk](#a_010)** | 23 |
| **Item 4.** | **[Controls and Procedures](#a_011)** | 23 |
| **[PART II - OTHER INFORMATION](#a_012)** | **[PART II - OTHER INFORMATION](#a_012)** | 24 |
| **Item 1.** | **[Legal Proceedings](#a_013)** | 24 |
| **Item 1A.** | **[Risk Factors](#a_014)** | 24 |
| **Item 2.** | **[Unregistered Sales of Equity Securities and Use of Proceeds](#a_015)** | 24 |
| **Item 3.** | **[Defaults Upon Senior Securities](#a_016)** | 24 |
| **Item 4.** | **[Mine Safety Disclosures](#a_017)** | 24 |
| **Item 5.** | **[Other Information](#a_018)** | 24 |
| **Item 6.** | **[Exhibits](#a_019)** | 25 |
| **[Signatures](#a_020)** | **[Signatures](#a_020)** | 26 |

---

**PART I. FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**OUR BOND INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS** 

(U.S. dollars in thousands, except per share and share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| ASSETS |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $3758 | $599 |
| &nbsp;&nbsp;&nbsp;Accounts receivable | 1704 | 1592 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 342 | 224 |
| Total current assets | 5804 | 2415 |
| Property and equipment, net | 89 | 86 |
| Total assets | $5893 | $2501 |
| LIABILITIES AND STOCKHOLDERS' DEFICIT |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $3196 | $2588 |
| &nbsp;&nbsp;&nbsp;Promissory Note | 2500 |  |
| &nbsp;&nbsp;&nbsp;Deferred revenue, current | 343 | 565 |
| &nbsp;&nbsp;&nbsp;Related party loan | 212 | 765 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | 1555 | 1555 |
| &nbsp;&nbsp;&nbsp;Accrued and other current liabilities | 2443 | 2645 |
| Total current liabilities | 10249 | 8118 |
| Long-term debt, net of current portion | 5882 | 5657 |
| Total liabilities | 16131 | 13775 |
| Commitments and contingencies (Note 11) |  |  |
| Mezzanine Equity |  |  |
| &nbsp;&nbsp;&nbsp;Convertible Preferred Stock, $0.0001 par value; 879,122 shares and 1,561,892 shares authorized, at March 31, 2026 and December 31, 2025, respectively, 577,951 and 1,237,717 shares issued and outstanding as of March 31, 2025 and December 31, 2025, respectively | 4735 | 11389 |
| &nbsp;&nbsp;&nbsp;Stockholders' deficit |  |  |
| &nbsp;&nbsp;&nbsp;Series preferred stock, $0.0001 par value; 149,120,878 shares and 148,438,108 shares authorized, at March 31, 2026 and December 31, 2025, respectively, 14,829,942 and 17,494,820 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2 | 2 |
| &nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value; 250,000,000 and 250,000,000 shares authorized at March 31, 2026 and December 31, 2025, respectively; 21,074,608 and 13,896,400 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 2 | 1 |
| &nbsp;&nbsp;&nbsp;Additional paid in capital | 131196 | 116556 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | (97) | (70) |
| &nbsp;&nbsp;&nbsp;Accumulated deficit | (146076) | (139152 |
| Total stockholders' deficit | (14973) | (22663 |
| Total liabilities, redeemable convertible preferred stock, and stockholders' deficit | $5893 | $2501 |

---

The accompanying footnotes are an integral part of these condensed consolidated financial statements.

**OUR BOND INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

(U.S. dollars in thousands, except per share and share amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended**<br> **December 31,** | **Three Months Ended**<br> **December 31,** |
|  | **March 31, 2026** | **March 31, 2025** |
| Revenue | $2347 | $2249 |
| Cost of revenues | 2300 | 2176 |
| Gross profit | 47 | 73 |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;Research and development | 691 | 555 |
| &nbsp;&nbsp;&nbsp;General and administrative | 2441 | 1026 |
| &nbsp;&nbsp;&nbsp;Sales and marketing | 3290 | 277 |
| Total operating expenses | 6422 | 1858 |
| Loss from operations | (6375) | (1785) |
| Other income (expense), net: |  |  |
| &nbsp;&nbsp;&nbsp;Financial expense, net | (292) | (377) |
| Income before income taxes | (6667) | (2162) |
| Income tax expense | 36 |  |
| Net loss | $(6703) | $(2162) |
| Net loss per share – basic and diluted | $(0.41) | $(0.73) |
| Weighted average number of common shares outstanding – basic and diluted | 16989 | 2964 |

---

The accompanying footnotes are an integral part of these condensed consolidated financial statements.

**OUR BOND INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS**

(U.S. dollars in thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| Net loss | $(6703) | $(2162) |
| Foreign currency translation adjustments, net of tax | (27) | (17) |
| Comprehensive loss | $(6730) | $(2179) |

---

The accompanying footnotes are an integral part of these condensed consolidated financial statements.

**OUR BOND INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY** 

**FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025**

(U.S. dollars in thousands, except share amounts)

(Unaudited)

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Stockholders' Deficit** | **Stockholders' Deficit** | **Stockholders' Deficit** | **Stockholders' Deficit** | **Stockholders' Deficit** | **Stockholders' Deficit** | **Stockholders' Deficit** | **Stockholders' Deficit** | **Mezzanine Equity** | **Mezzanine Equity** |
| | **Series Preferred<br> Stock** | **Series Preferred<br> Stock** | **Common Stock<br> Voting** | **Common Stock<br> Voting** | | | | | **Series**<br> **Preferred**<br> **Stock** | **Series**<br> **Preferred**<br> **Stock** |
| <br>**(U.S. dollars in thousands)** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional**<br> **Paid-in** <br>**Capital** | **Accumulated Other<br> Comprehensive<br>** <br>**Income (Loss)** | **Accumulated<br>** <br>**Deficit** | **Total**<br> **Stockholders'**<br>**Deficit** | **Shares** | **Amount** |
| **Balance as of January 1, 2026** | 17494820 | $2 | 13896400 | $1 | $116556 | $(70) | $(139152) | $(22663) | 1237717 | 11389 |
| &nbsp;&nbsp;&nbsp;Stock based compensation related to options granted to employees and non-employees |  |  |  |  | 203 |  |  | 203 |  |  |
| &nbsp;&nbsp;&nbsp;Exercise of options and vesting of early exercise |  |  | 96 | \*— |  |  |  | \*— |  |  |
| &nbsp;&nbsp;&nbsp;Issuance of common shares for service |  |  | 161963 | \*— | 2035 |  |  | 2035 |  |  |
| &nbsp;&nbsp;&nbsp;Issuance of common shares related to direct listing |  |  | 418219 | \*— | \*— |  |  | \*— |  |  |
| &nbsp;&nbsp;&nbsp;Exercise of Common Warrants to Common Stock |  |  | 4479 | \*— | 20 |  |  | 20 |  |  |
| &nbsp;&nbsp;&nbsp;Issuance of Series D convertible preferred stock- net of issuance costs |  |  |  |  |  |  |  |  | 324175 | 2679 |
| &nbsp;&nbsp;&nbsp;Conversion of Series E Preferred Stock into Common Stock |  |  | 1477857 | 1 | 6828 |  |  | 6829 | (682770) | (6828) |
| &nbsp;&nbsp;&nbsp;Exercise of Series D Common Warrants into Common Stock - net of issuance costs |  |  | 8098 | \*— | 93 |  |  | 93 |  |  |
| &nbsp;&nbsp;&nbsp;Conversion of Series D Convertible Preferred Stock into Common Stock |  |  | 19433 | \*— | 196 |  |  | 196 | (24000) | (196) |
| &nbsp;&nbsp;&nbsp;Exercise of Series C Common Warrants into Common Stock - net of issuance costs |  |  | 1033335 | \*— | 3121 |  |  | 3121 |  |  |
| &nbsp;&nbsp;&nbsp;Conversion of Series C Convertible Preferred Stock into Common Stock |  |  | 1367742 | \*— | 2309 |  |  | 2309 | (277171) | (2309) |
| &nbsp;&nbsp;&nbsp;Conversion of B-2 Preferred Stock into Common Stock | (607775) | \*— | 607775 | \*— |  |  |  | \*— |  |  |
| &nbsp;&nbsp;&nbsp;Conversion of B-3 Preferred Stock into Common Stock | (2057103) | \*— | 2057102 | \*— |  |  |  | \*— |  |  |
| &nbsp;&nbsp;&nbsp;Common Stock Dividend |  |  | 22109 | \*— | 85 |  | (85) | \*— |  |  |
| &nbsp;&nbsp;&nbsp;Direct Listing Costs |  |  |  |  | (250) |  |  | (250) |  |  |
| &nbsp;&nbsp;&nbsp;Cash Dividend |  |  |  |  |  |  | (136) | (136) |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments, net of tax |  |  |  |  |  | (27) |  | (27) |  |  |
| &nbsp;&nbsp;&nbsp;Net loss |  |  |  |  |  |  | (6703) | (6703) |  |  |
| **Balance as of March 31, 2026** | 14829942 | $2 | 21074608 | $2 | $131196 | $(97) | $(146076) | $(14973) | 577951 | 4735 |
| **Balance as of January 1, 2025** | 26560266 | $3 | 2963695 | $1 | $111509 | $44 | $(128070) | $(16513) |  |  |
| &nbsp;&nbsp;&nbsp;Stock based compensation related to options granted to employees and non-employees |  |  |  |  | 82 |  |  | 82 |  |  |
| &nbsp;&nbsp;&nbsp;Exercise of options and vesting of early exercise |  |  | 609 | \*— | \*— |  |  | \*— |  |  |
| &nbsp;&nbsp;&nbsp;Issuance of Series CF preferred stock | 1033601 | \*— |  |  | 2476 |  |  | 2476 |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustments, net of tax |  |  |  |  |  | (17) |  | (17) |  |  |
| &nbsp;&nbsp;&nbsp;Net income |  |  |  |  |  |  | (2162) | (2162) |  |  |
| **Balance as of March 31, 2025** | 27593867 | $3 | 2964304 | $1 | $114067 | $27 | $(130232) | $(16134) |  |  |

---

*\** *)Represents less than $1*

The accompanying footnotes are an integral part of these condensed consolidated financial statements.

**OUR BOND INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

(U.S. dollars in thousands)

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| **CASH FLOWS FROM OPERATING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;Net loss | $(6703) | $(2162) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash flows used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 203 | 82 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 10 | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock issued for legal and other services | 2035 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest related to Convertible Promissory Notes and Loan Facility | 226 | 368 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (112) | 850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | (119) | (29) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 607 | (356) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | (219) | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued and other current liabilities | (338) | (193) |
| &nbsp;&nbsp;&nbsp;Net cash flows used in operating activities | (4410) | (1416) |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases and sell of property and equipment | (11) |  |
| &nbsp;&nbsp;&nbsp;Net cash flows used in by investing activities | (11) |  |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments as part of related party loans | (555) | (350) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of Series CF-1 Preferred Stock |  | 2535 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of Series CF-1 Preferred Stock fundraising fees |  | (58) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of Series D convertible preferred stock | 2950 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of Series D convertible preferred stock - issuance costs | (271) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Issuance of Promissory Note | 3000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of Promissory Note | (500) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of Series C Common Warrants | 3356 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of Series C Common Warrants - issuance costs | (235) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of Series D Common Warrants | 100 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of Series D Common Warrants - issuance costs | (7) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of Common Stock Warrants | 19 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Direct Listing Costs | (250) |  |
| &nbsp;&nbsp;&nbsp;Net cash flows provided by financing activities | 7607 | 2127 |
| &nbsp;&nbsp;&nbsp;Effect of exchange rate on cash | (27) | (17) |
| &nbsp;&nbsp;&nbsp;Change in cash, cash equivalents and restricted cash | 3159 | 694 |
| &nbsp;&nbsp;&nbsp;Cash, cash equivalents, and restricted cash beginning of period | 599 | 726 |
| &nbsp;&nbsp;&nbsp;Cash, cash equivalents, and restricted cash end of period | $3758 | $1420 |
| **SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:** |  |  |
| &nbsp;&nbsp;&nbsp;Cash paid for income taxes, net | $37 | $28 |
| **SUPPLEMENTAL DISCLOSURES OF NON-CASH FLOW INFORMATION:** |  |  |
| &nbsp;&nbsp;&nbsp;Common Stock Dividend | $85 |  |
| &nbsp;&nbsp;&nbsp;Accounts payable associated with equity financing and unpaid dividends | $658 |  |
| &nbsp;&nbsp;&nbsp;Common stock issued in connection with a direct listing | $13801 |  |
| &nbsp;&nbsp;&nbsp;Conversion of Preferred Stock into Common Stock | $9333 |  |

---

The accompanying footnotes are an integral part of these condensed consolidated financial statements.

**OUR BOND INC.**

**NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**<u>NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</u>**

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Securities and Exchange Commission, or SEC, Regulation S-X.

The December 31, 2025 consolidated balance sheet was derived from our audited consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC, but does not include all disclosures required by U.S. GAAP for annual financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments considered necessary for a fair presentation of results of operations and financial position, have been included. The results for the interim periods presented are not necessarily indicative of the results expected for any future period. The following information should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

The accompanying financial statements have been prepared on a going concern basis. However, the Company has incurred recurring losses and negative operating cash flows, and its current liabilities exceed its current assets as of March 31, 2026. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

Management is pursuing several strategies to mitigate these conditions, including capital raising, and believes that these actions will provide the necessary liquidity for at least the next twelve months. Nevertheless, there can be no assurance that such plans will be successfully implemented or yield the intended financial benefits.

Accordingly, there is a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern, and therefore it may be unable to realize its assets and discharge its liabilities in the normal course of business. The financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern.

Significant Accounting Policies

There have been no material changes to the Company's significant accounting policies disclosed in Note 4 - Significant Accounting Policies, to the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.

On an on-going basis, we evaluate our estimates, including those related to accounts receivable, cash equivalents and marketable securities, income taxes, litigation, non-marketable equity securities, other contingencies, property, plant, and equipment, revenue recognition, and stock-based compensation. The Company bases its estimates on historical experience, known trends, and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts, and experience. Changes in estimates are recorded prospectively in the period in which they become known. Actual results could significantly differ from those estimates.

Recently Issued Accounting Pronouncements

Recent Accounting Pronouncements Not Yet Adopted

In December 2023, the FASB issued ASU No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures ("ASU 2023-09"). ASU 2023-09 requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The ASU is effective for public business entities for annual periods beginning after December 15, 2024. For all other entities, the standard is effective for annual periods beginning after December 15, 2025. Early adoption is permitted. The Company is currently evaluating the impact of this ASU on its consolidated financial statements.

In November 2024, the FASB issued ASU No. 2024-03 Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03") a new accounting standard requiring disclosures of certain additional expense information on an annual and interim basis, including, among other items, the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization included within each income statement expense caption, as applicable. We expect to adopt this standard in our fiscal year 2027 annual report. We do not expect the adoption of this standard to have a material impact on our Consolidated Financial Statements other than additional disclosures.

**Note 2 – Revenue**

***Disaggregation of Revenue***

The Company recognizes revenue classified in services and other either at a point in time or over time. Revenue by point in time and over time was as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| SaaS revenue recognized over time | $363 | $330 |
| Services and other revenue recognized point in time | 1984 | 1919 |
| &nbsp;&nbsp;&nbsp;Total revenue | $2347 | $2249 |

---

The deferred revenue balance represents payments received for performance obligations not yet satisfied. The following table shows the changes in deferred revenue during the three months ended March 31, 2026, and 2025 respectively (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| Balance at beginning of period | $562 | $776 |
| &nbsp;&nbsp;&nbsp;Deferred revenue additions during period | 223 | 262 |
| &nbsp;&nbsp;&nbsp;Revenue recognized during period | (442) | (271) |
| Balance at end of period | $343 | $767 |

---

Revenue recognized during the three months ended March 31, 2026 that was included in deferred revenue as of December 31, 2025 was $299. Revenue recognized during the three months ended March 31, 2025 that was included in deferred revenue as of December 31, 2024 was $260.

Revenue allocated to remaining performance obligations that are unsatisfied (or partially unsatisfied), which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods, will be recognized within one year or less.

**Note 3 – Segment and Geographical Information**

The Company's security solutions are substantially similar in nature and as a result the Company operates as one operating and reportable segment. Operating segments are defined as components of an enterprise for which separate financial information is regularly evaluated by the chief operating decision maker ("CODM"), which is the Company's Chief Executive Officer, in deciding how to allocate resources and assess performance. The Company's CODM evaluates the financial information presented on a consolidated basis for the purposes of making operating decisions, assessing financial performance and allocating resources. The CODM evaluates performance based on income (loss) from operations, which is calculated as revenues less cost of sales and operating expenses. This measure excludes interest income (expense), other income (expense) and income taxes. The CODM reviews income (loss) from operations on a monthly basis to assess the Company's ability to generate earnings from its core activities and to monitor operating efficiency. This analysis includes comparisons of current results to budgeted amounts, prior periods and internal forecasts. Based on these evaluations, the CODM determines whether to adjust operating plans, modify pricing strategies, implement cost-control initiatives or adjust resource levels in specific functional areas. In addition, the CODM uses income (loss) from operations to make decisions about the allocation of resources, including approving capital expenditures, prioritizing research and development initiatives, adjusting headcount in specific departments and determining marketing spend. The CODM also considers this measure when evaluating the performance of the management team and establishing annual incentive compensation targets. Income/loss from operations is the Company's primary measure of profit or loss, and all costs and expenses categories on the Company's consolidated statement of operations, as well as stock-based compensation, depreciation and amortization expenses, are significant. Refer to Note 9 for additional information about the Company's stock-based compensation expense.

Revenue by geographic area is designated based upon the billing location of the customer as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| United States | $2338 | $2238 |
| Isreal | 9 | 11 |
| &nbsp;&nbsp;&nbsp;Total revenue | $2347 | $2249 |

---

Property and equipment by geographic areas was as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| United States | $15 | $18 |
| Israel | 70 | 68 |
| France | 4 |  |
| &nbsp;&nbsp;&nbsp;Total property and equipment | $89 | $86 |

---

**Note 4 – Earnings Per Share**

Basic net loss per share is computed by dividing reported net loss by the weighted-average number of common shares outstanding for the reported period. In computing diluted earnings per share, common share equivalents are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be antidilutive. Since the Company was in a net loss for all periods presented in these consolidated financial statements, diluted net loss per share was the same as basic net loss per share.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| Numerator: | (in thousands, except per share data) | (in thousands, except per share data) |
| &nbsp;&nbsp;&nbsp;Net loss attributable to common stockholders | $(6703) | $(2162) |
| &nbsp;&nbsp;&nbsp;Less: preferred dividends | (221) |  |
| &nbsp;&nbsp;&nbsp;Net loss attributable to common shareholders | (6924) | (2162) |
| Denominator: |  |  |
| &nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding | 16989 | 2964 |
| Net loss per common share | $(0.41) | $(0.73) |

---

The following potential common share equivalents were excluded from the calculation of diluted net income per share because their effect would have been anti-dilutive in the period presented (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
| Convertible preferred stock | 15514 | 20782 |
| Common Stock Warrants | 25376 | 26421 |
| Preferred Stock Warrants | 247 | 247 |
| Stock options | 14903 | 7337 |
| &nbsp;&nbsp;&nbsp;Total potential common stock excluded from net loss per share | 56040 | 54787 |

---

**Note 5 – Balance Sheet Detail**

Prepaid expenses and other current assets consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Prepaid expenses | $131 | $37 |
| Other current assets | 211 | 187 |
| &nbsp;&nbsp;&nbsp;Total prepaid expenses and other current assets | $342 | $224 |

---

Property and equipment, net consisted of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,** | **December 31,** |
|  | **2026** | **2025** |
| Computers and peripheral equipment | $423 | $411 |
| Office furniture and equipment | 46 | 46 |
| Electronic equipment | 290 | 290 |
| Leasehold improvements | 18 | 18 |
|  | 777 | 765 |
| Less: accumulated depreciation | (688) | (679) |
| &nbsp;&nbsp;&nbsp;Total property and equipment, net | $89 | $86 |

---

Depreciation expenses for the three months ended March 31, 2026 and 2025 amounted to $10 and $12, respectively.

Accrued and other current liabilities was composed of the following (in thousands):

---

| | | |
|:---|:---|:---|
|  | **March 31,**<br>**2026** | **December 31,**<br>**2025** |
| Employee and related accruals | $693 | $822 |
| Accrued expenses | 1528 | 1686 |
| Dividends payable | 195 | 61 |
| Other | 27 | 76 |
| Total accrued and other current liabilities | $2443 | $2645 |

---

**Note 6 – Loan and Promissory Note**

In June 2019 the Company entered into Loan and Security agreement (the "Loan Facility") in the amount of $9,999. The principal amount outstanding under each Advance shall accrue at the following rate per annum rate equal to the greater of six and one-half percentage points (6.50%) above the Prime Rate of 12.00%, which interest shall be payable monthly. Immediately upon the occurrence and during the continuance of an event of default as defined in the contract, the Obligations shall bear interest at a rate per annum which is four percentage points (4.0%) above the rate that is otherwise applicable thereto. Additionality, concurrently with the grant of the loan, the Company issued warrants to 1,872,993 shares of preference Series A, per value 0.0001$ per share, and exercise price of 0.2803$ per share. The Warrants expiration date was settled as the earlier of (1) the date that is ten (10) years after the original Issue Date, (2) the Initial Public Offering and (3) a Liquid Acquisition.

Between 2021 and 2024, the Loan Facility was amended multiple times to defer and restructure principal and interest payments and extend the applicable forbearance period through the earlier of December 31, 2025 or the closing of a qualifying equity financing.

In November 2023, a total of $3,152 from the loan were converted into 6,466,194 Series B-1 Preferred Stock of $0.0001 par value as part of Series B Preferred Stock Purchase Agreement. Additionally, the warrants mentioned above were cancelled and replaced by a new 741,435 Series B-1 warrant, per value 0.0001$ per share, and exercise price of 0.4875$ per share. The Series B-1 Warrants shall be convertible, at the option of the holder, at any time after the date on which such warrant was issued by the Company, into such number of fully paid and non-assessable Common Stock as is determined by dividing the value of the warrant.

On August 6, 2025, the Company entered into a Securities Purchase and Conversion Agreement. Pursuant to the Agreement, the Company converted 50% of its outstanding loan obligations, totaling approximately $6.8 million, into 682,770 shares of its Series E Convertible Preferred Stock ("Series E Preferred"), stated value $10.00 per share. As the fair value of the Series E Preferred Stock issued approximated the carrying value of the debt extinguished, no gain or loss was recognized. The Series E Preferred is convertible into shares of the Company's common stock and accrues dividends on the stated value thereof at the same rate as the original loan. Dividends are payable, at the Company's election, in cash or shares of common stock. The initial conversion price for the Series E Preferred is $4.62 per share. Upon the holder of the Company's Series C Preferred Stock receiving a return of capital in the minimum amount of $8,000,000, the conversion price for the Series E Preferred will adjust to $3.75 per share. Concurrently with the Securities Purchase and Conversion Agreement, the Company entered into a Waiver and Twenty-seventh Amendment to Loan and Security Agreement (the "Amendment") with the holder of its senior secured debt. Under the Amendment, the remaining approximately $6.8 million in loan obligations are subject to a modified repayment schedule. Upon the earlier of: (i) the Company closing one or more equity financings yielding an aggregate amount of net cash proceeds of at least $20,000,000; or (ii) June 30, 2026, the Company shall make twenty-four (24) consecutive equal monthly installments of principal and interest based on a thirty-six (36) month amortization period, with the balance of the obligation due and payable on the 25th month.

The total interest expenses and accrued interest for the three months ended March 31, 2026 were $226 and $610, respectively, and as for three months ended March 31, 2025, were $350 and $3,158, respectively. Any unpaid interest was accrued as part of the loan.

On March 1, 2026, the Company issued a Promissory Note in the principal amount of $2,500,000. The Promissory Note bears interest at a rate of 10% per annum and matures on September 1, 2026. The Company is required to apply 25% of the net proceeds from any future offerings or issuances of the Company's securities toward repayment of the Promissory Note until it is paid in full. In the event of default, the Promissory Note will bear interest at a rate of 24% per annum, and any late payments will be subject to a late fee equal to 10% of the overdue amount.

The total interest expenses and accrued interest for the three months ended March 31, 2026 were $21 and $0, respectively.

**Note 7 – Related Party**

Since the company's establishment, the company's founder and CEO has also been the largest investor who participated - either directly or through entities under his control - in all funding rounds in a total amount of approximately $44.67 million.

In 2023, the Company entered into Unsecured Convertible Revolving Promissory Note (the "Note") with its main shareholder in the amount of up to $3,000. At any time, the Noteholder may, in its sole discretion, lend to the Company from time to time until the first-year anniversary of the Effective Date such amounts as may be requested by the Company in accordance with the terms and conditions of this Note. The principal amount outstanding under this Note from time to time shall bear interest at a rate per annum equal to the Applicable Federal Rate.

During the three months ended March 31, 2026 and 2025, the Company repaid $555 and $350, respectively, of the outstanding balance under the Revolving Promissory Note. As of March 31, 2026 and December 31, 2025, the outstanding balance under the Revolving Promissory Note was $212 and $765, respectively.

The total interest expenses recorded in the three months ended March 31, 2026 and 2025 were $2 and $18, respectively.

**Note 8 – Preferred Stock and Common Stock**

**Stock reverse split**

On September 19, 2025, the Company effected a 1-for-3 reverse stock split (the "Reverse Stock Split"), pursuant to which every three shares of the Company's issued and outstanding common stock were combined into one share of common stock. The par value per share of the common stock remained unchanged at $0.0001. The total number of issued and outstanding shares of common stock was reduced proportionately, and the number of issued preferred shares, warrants, and stock options were adjusted on the same basis. The Reverse Stock Split did not affect the Company's total stockholders' deficit and the number of authorized shares remained unchanged. All share amounts have been retroactively adjusted, as if the Reverse Stock Split had occurred at the beginning of all periods presented.

**Composition of stock capital**

The stock capital of the Company as of March 31, 2026 and December 31, 2025 is comprised of stock of $0.0001 par value each, as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|  | **Authorized** | **Issued and<br> outstanding** | **Authorized** | **Issued and<br> outstanding** |
| Common stock |  |  |  |  |
| Common stock voting | 200000000 | 21074608 | 200000000 | 10315901 |
| Common stock non-voting | 50000000 |  | 50000000 | 3580499 |
| &nbsp;&nbsp;&nbsp;Total common stock | 250000000 | 21074608 | 250000000 | 13896400 |
| Preferred stock |  |  |  |  |
| Series B-1 preferred stock | 25356256 | 8204944 | 25356256 | 8204944 |
| Series B-2 preferred stock | 27463149 | 1520962 | 27463149 | 2128737 |
| Series B-3 preferred stock | 21453390 | 5094036 | 21453390 | 7151139 |
| Series CF-1 preferred stock |  |  | 14128084 |  |
| Series CF-2 preferred stock |  |  | 2900000 |  |
| Series F preferred stock | 10000 | 10000 | 10000 | 10000 |
| Non-designated preferred stock | 74838083 |  | 57127229 |  |
| &nbsp;&nbsp;&nbsp;Total preferred stock | 149120878 | 14829942 | 148438108 | 17494820 |

---

**Common Stock**

Common Stock confer upon their holders the right, among others, to participate and vote in the Company's stockholders meeting, participation in the Company's distributable earnings and participation in the distribution of the Company's assets upon its liquidation. The stockholders' liability is limited to the redemption of the par value of their stock.

**Preferred Stock**

Preferred stock has been designated into several classes, consisting of Series B-1 Preferred Stock, Series B-2 Preferred Stock, Series B-3 Preferred Stock, Series CF-1 Preferred Stock, Series CF-2 Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock.

The Series C Preferred Stock and the Series D Preferred Stock are not mandatorily redeemable; however, they are contingently redeemable upon the occurrence of certain events that are not solely within the control of the Company. Accordingly, they are classified as temporary equity (mezzanine equity) in the Company's consolidated balance sheets.

All issued and outstanding shares of the Series CF-1 Preferred Stock, Series CF-2 Preferred Stock and Series E Preferred Stock were converted into shares of the Company's common stock. As a result, no shares of such series remained issued or outstanding as of March 31, 2026, and the Company withdrew the related Certificates of Designation.

Series B-1, B-2, and B-3 Preferred Stock

*Voting rights:*

The holders of Series B Preferred Stock are entitled to one vote for each share of Common stock on an as-converted basis and shall vote together, along with holders of other Preferred Stock entitled to vote thereon with the holders of Common Stock as a single class. The holders of the Series B Preferred stock shall be entitled to vote on all matters on which holders of Common stock are entitled to vote.

*Conversion:*

Each share of Series B Preferred Stock shall be convertible, at the option of the holder, at any time after the date on which such stock was issued by the Company, into such number of fully paid and non-assessable Common Stock as is determined by dividing the applicable original issuance price by the applicable conversion price in effect at the time of conversion. Each share of Series B Preferred Stock shall automatically be converted into Common Stock immediately upon the earlier of (i) the closing of a Qualified IPO (as such term is defined in the applicable certificate of designation), as such or (ii) written consent or agreement of the majority of the outstanding shares of Preferred Stock voting together on an as-converted to Common Stock basis that are entitled to vote on such matter. In the event that the Company issues any new securities, for a consideration per share lower than the applicable conversion price of the applicable Series B Preferred Stock, the applicable conversion price for the applicable Series B Preferred Stock shall be readjusted to reflect the lower consideration paid for the applicable Series B Preferred Stock as set forth in the applicable certificate of designation.

*Liquidation preference:*

The Company's Series B Preferred Stock is entitled to a non-participating liquidation preference. In the event of any liquidation, dissolution or winding up of the Company, assets or proceeds shall be distributed as follows: (i) the holders of Series B-1 Preferred Stock and Series B-2 Preferred Stock (along with holders of Series CF Preferred Stock on a pari passu basis) shall be paid before any payment is paid to the remaining stockholders (other than holders of Series C Preferred Stock), of an amount per share equal to two (2) times their original issue price and any unpaid dividend and subsequently (ii) the holders of Series B-3 Preferred Stock shall be paid before any payment is paid to holders of Common Stock and Series F Preferred Stock, of an amount per share equal to two (2) times their original issue price and any unpaid dividend.

Series C Preferred Stock

*Voting rights:*

The holders of Series C Preferred Stock shall have no voting rights, except as required by law and as expressly provided in the certificate of designation.

*Conversion:*

Shares of Series C Preferred Stock have a stated value of $10.00 per shares and are convertible to the common stock at a price of $2.0265 per share of common stock. Conversions of Series C Preferred Stock are limited such that no conversion will be allowed to the extent that, immediately following the conversion, the holder, its affiliates or any other person acting as a group, would beneficially own in excess of 9.99% of the Company's issued and outstanding common stock

*Liquidation preference:*

The holders of Series C Preferred Stock are entitled to a non-participating liquidation preference. In the event of any liquidation, dissolution or winding up of the Company, assets or proceeds shall be distributed to the holders of Series C Preferred Stock first who shall be paid before any payment is paid to the remaining stockholders, of an amount per share equal to the greater of (i) 200% of stated value (as defined therein) or (ii) the amount the holder would receive if such holder converted such Series C Preferred Stock into Common Stock immediately prior to the date of such payment.

*Dividends:*

Holders of Series C Preferred Stock are entitled to dividends payable on the stated value thereof, commencing from on the issuance date, at an annual rate of 8%, payable monthly in arrears on the stated value.

Series D Preferred Stock

*Voting rights:*

The holders of Series D Preferred Stock shall have no voting rights, except as required by law and as expressly provided in the certificate of designation.

*Conversion:*

Shares of Series D Preferred Stock have a stated value of $10.00 per shares and are convertible to the common stock at a price of $12.35 per share of common stock. Conversions of Series C Preferred Stock are limited such that no conversion will be allowed to the extent that, immediately following the conversion, the holder, its affiliates or any other person acting as a group, would beneficially own in excess of 9.99% of the Company's issued and outstanding common stock. See also note 12.

*Liquidation preference:*

The holders of Series D Preferred Stock are entitled to a non-participating liquidation preference. In the event of any liquidation, dissolution or winding up of the Company, assets or proceeds shall be distributed to the holders of Series D Preferred Stock first who shall be paid before any payment is paid to the remaining stockholders, of an amount per share equal to the greater of (i) 200% of stated value (as defined therein) or (ii) the amount the holder would receive if such holder converted such Series D Preferred Stock into Common Stock immediately prior to the date of such payment.

 

*Dividends:*

Holders of Series D Preferred Stock are entitled to dividends payable on the stated value thereof, commencing from on the issuance date, at an annual rate of 8%, payable monthly in arrears on the stated value.

Series F Preferred Stock

*Voting rights:*

The holders of Series F Preferred Stock are entitled to cast 40,000 votes for each one (1) share of Series F Preferred Stock and shall vote together, along with holders of other Preferred Stock entitled to vote thereon, with the holders of Common Stock as a single class. The holders of the Series F Preferred stock shall be entitled to vote on all matters on which holders of Common stock are entitled to vote.

*Conversion:*

Each share of Series F Preferred Stock shall be convertible, at the option of the holder, at any time after the date on which such stock was issued by the Company, into one (1) share of fully paid and non-assessable Common Stock.

*Liquidation preference:*

The Company's Series F Preferred Stock are entitled to participate in any distribution out of the assets of the Company on an equal basis per share with the holders of the Common Stock. For the purposes of such distribution, holders of Series F Preferred Stock shall be treated as if all shares of Series F Preferred Stock had been converted to Common Stock immediately prior to the distribution.

**Dividends**

During the three months ended March 31, 2026, the Company recorded total dividends of $136. As of March 31, 2026, accrued dividends payable were $197.

**Issuance of Preferred Stock and Warrants**

On June 2025, the Company designated a new class of Series F Preferred Stock consisting of 10,000 authorized shares (the "Series F Preferred Stock"). The Series F Preferred Stock were issued through the conversion of an equivalent number of shares of the Company's founder and CEO Common Stock on a pre–reverse stock split basis (was not affected by the subsequent reverse stock split) and is entirely held by him. Each share of Series F Preferred Stock entitles the holder to cast 40,000 votes on all matters submitted to the Company's shareholders or acted upon by written consent. In addition, each three shares is convertible, at the option of the holder, into one share of the Company's Common Stock. The conversion of the founder and CEO's Common Stock into Series F Preferred Stock was accounted for as an equity reclassification, as it did not result in a change in control or economic ownership. Accordingly, no gain or loss was recognized.

On June 2025, the Company entered into a Series C Preferred Stock Purchase Agreement (the "Series C SPA") with a new investor. According to the Series C SPA, Company issued an aggregate of 329,671 shares of Series C Preferred Stock, par value $0.0001 per share, together with warrants to purchase 4,000,000 shares of common stock, for an aggregate consideration of $3,000. Series C Preferred Stock features a stated value of $10.00 per share and is convertible to common stock at a price of $2.0265 per share. The warrants are exercisable at a price of $3.2475 per share, with expiration dates as follows: 1,000,000 warrants have an expiration date of eight (8) months, 1,000,000 warrants have an expiration date of sixteen (16) months, and 2,000,000 warrants have an expiration date of two (2) years from the issuance date. See also note 12.

On July 2025, the Company entered into a listing agreement, under regulation Crowdfunding (also known as Reg CF), whereby the Company agrees to sell securities to eligible investors through the funding portal through special purpose vehicle. On September 2025 the Company closed the financing round, raising a total of $819 and issued 212,033 Series CF-2 Preferred Stock with par value of $0.0001 each, at a price per stock of $2.1234; The total fundraising fees recorded were $56.

On August 6, 2025, the Company entered into a Securities Purchase and Conversion Agreement. Pursuant to the Agreement, the Company converted 50% of its outstanding loan obligations, totaling approximately $6.8 million, into 682,770 shares of its Series E Convertible Preferred Stock ("Series E Preferred"), stated value $10.00 per share. The Series E Preferred is convertible into shares of the Company's common stock and accrues dividends on the stated value thereof at the same rate as the original loan. Dividends are payable, at the Company's election, in cash or shares of common stock. The initial conversion price for the Series E Preferred is $4.62 per share. During the three months ended March 31, 2026, the Company issued 22,109 shares of its common stock as stock dividends, and as of March 31, 2026, an aggregate of 121,457 shares of common stock had been issued as stock dividends. See also note 6.

On October 15, 2025, all outstanding shares of the Company's Series CF-1 Preferred Stock and Series CF-2 Preferred Stock were converted into shares of non-voting common stock. Subsequently, on February 2, 2026, all outstanding shares of non-voting common stock were converted into shares of the Company's voting common stock.

On October 27, 2025, the Company entered into a Securities Purchase Agreement (the "SPA") for the issuance and sale of a total of 549,451 shares of Series D Preferred Stock and warrants to the purchase a total of 25,000,000 shares of common stock. At the initial closing under the SPA on October 27, 2025, the Company issued 109,891 shares of Series D Preferred Stock for consideration of $1,000, together with warrants to purchase a total of 25,000,000 shares of common stock exercisable at a price of $12.35 per share (the "Warrants"), with expiration dates as follows: 16,000,000 warrants have an expiration date of nine (9) months, 3,000,000 warrants have an expiration date of sixteen (16) months, and 6,000,000 warrants have an expiration date of two (2) years from the issuance date. The Warrants may not be exercised on a cashless basis unless, upon the listing of the Company's common stock on any recognized stock exchange pursuant to an effective registration statement, there is no effective registration statement covering, or no current prospectus available for, the free resale of the warrant exercise shares by the holder. On December 2025, the Company completed three additional closings under the SPA for an aggregate consideration of $1,050, pursuant to which the Company issued an additional 115,385 shares of Series D Preferred Stock. On January 12, 2026, at a fifth closing under the SPA, the Company issued 93,407 additional shares of Series D Preferred Stock for additional consideration of $850. On January 30, 2026, at a sixth closing under the SPA, we issued 131,867 additional shares of Series D Preferred Stock for consideration of $1,200. On February 4, at a final closing under the SPA, the Company issued 98,902 additional shares of Series D Preferred Stock for consideration of $900. Total issuance costs related to the Series D Preferred Stock were $506. See also note 12.

On November 3, 2025, an aggregate of 7,025,651 shares of Series B-2 Preferred Stock were converted into common stock. On November 3, 2025, an aggregate of 7,025,651 shares of Series B-2 Preferred Stock were converted into common stock. In addition, on February 4, 2026, an additional 607,775 shares of Series B-2 Preferred Stock were converted into common stock. All such conversions were completed in accordance with the original terms of the applicable agreements, and accordingly, no gain or loss was recognized upon conversion.

On February 4, 2026, the Company issued 161,963 shares of common stock to certain service providers in exchange for services rendered, for aggregate non-cash consideration of $2,035,000, based on the market value of the common stock at the time of the agreement.

On February 4, 2026, pursuant to the terms of an engagement agreement entered into in connection with the Company's direct listing, upon (i) the successful consummation of the direct listing and (ii) the closing of financings with aggregate gross proceeds of at least $5.0 million, the Company issued 418,219 shares of common stock to certain designees, representing 0.5% of the Company's outstanding common stock on a fully diluted basis. The shares were issued as consideration for investment banking and advisory services and had an aggregate value of approximately $33,801,000, based on an implied value of $33.00 per share. The fair value of the shares issued was recorded as an increase to additional paid-in capital, with an offsetting reduction to additional paid-in capital as equity issuance costs related to the direct listing.

On February 5, 2026, all 682,770 outstanding shares of the Company's Series E Convertible Preferred Stock were converted into 1,477,857 shares of the Company's common stock in accordance with the terms of the Series E Preferred. Following the conversion, no shares of Series E Preferred remained outstanding.

On March 1, 2026, the Company entered into Amendment No. 1 (the "Amendment") to a Warrant to Purchase Shares of Common Stock originally issued on October 27, 2025 (the "Warrant"). The Warrant provides for the purchase of up to 16,000,000 shares of the Company's common stock at an exercise price of $12.35 per share and expires on July 27, 2026. Pursuant to the Amendment, the exercise price for 12,000,000 shares underlying the Warrant was temporarily reduced as follows: (i) $2.25 per share for 4,500,000 shares for a period of 60 days; (ii) $2.75 per share for 3,750,000 shares for a period of 60 days; and (iii) $3.25 per share for 3,750,000 shares for a period of 75 days. Upon expiration of the reduced exercise price periods, the exercise price for the applicable warrants will revert to the original exercise price of $12.35 per share. All other terms and conditions of the Warrant remain unchanged, and the Amendment was effected in accordance with the terms of the applicable agreements; accordingly, no gain or loss was recognized in connection with the transaction. See also note 12.

On March 3, 2026 and March 17, 2026, an aggregate of 2,057,102 shares of Series B-3 Preferred Stock were converted into common stock.

During the three months ended March 31, 2026, holders of Series D preferred stock converted an aggregate of 24,000 shares of Series D preferred stock with a stated value of $10.00 per share into 19,433 shares of common stock at a conversion price of $12.35 per share. In addition, holders of Series C preferred stock converted an aggregate of 277,171 shares of Series C preferred stock with a stated value of $10.00 per share into 1,367,742 shares of common stock at a conversion price of $2.0265 per share.

During the three months ended March 31, 2026, the Company issued 8,098 shares of common stock upon the exercise of warrants from the Series D financing, resulting in aggregate proceeds of approximately $100,010. In addition, the Company issued 1,033,335 shares of common stock upon the exercise of Series C warrants at an exercise price of $3.2475 per share, resulting in aggregate proceeds of approximately $3.35 million. The Company incurred issuance costs of approximately $242,000 related to the warrant exercises.

**Note 9 – Stock-Based Compensation**

The Equity Incentive Plan provides for the Company to grant ISOs, and NSOs to employees, advisers, and directors. As of March 31, 2026 there were 15,111,193 equity awards authorized including 208,135 awards that were exercised to common stock.

***Stock Options***

Stock options represent the right to purchase shares of common stock on the date of exercise at a stated exercise price. The exercise price of a stock option generally must be at least equal to the fair market value of the common stock on the date of grant. Options vest over a period of time not to exceed 10 years from the grant date. For the three months ended March 31, 2026 and 2025, the Company recorded stock-based compensation expense of $203 and $82, respectively.

The terms of the plan permit certain option holders to exercise options before their options are vested, subject to certain limitations. Upon early exercise, the awards become subject to a restricted stock agreement. The shares of restricted stock granted upon early exercise of the options are subject to the same vesting provisions in the original stock option awards. Shares issued as a result of early exercise that have not been vested are subject to repurchase by the Company upon termination of the purchaser's employment, at the price paid by the purchaser. Such shares are not deemed to be issued for accounting purposes until they vest.

The following table summarizes the Company's stock option activity and related information:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Number of<br> Shares** | **Weighted<br> Average<br> Exercise Price** | **Aggregate**<br> **Intrinsic Value**<br> **(in thousands)** | **Weighted<br> Average<br> Remaining Life** |
| Outstanding as of December 31, 2025 | 7336803 | $0.76 | $3716928 | 8.71 |
| &nbsp;&nbsp;&nbsp;Granted | 7589660 | $1.31 | $- |  |
| &nbsp;&nbsp;&nbsp;Exercised during period |  | $- |  |  |
| &nbsp;&nbsp;&nbsp;Forfeited | 631 | $0.95 | $- |  |
| &nbsp;&nbsp;&nbsp;Expired | 12870 | $1.15 |  |  |
| Outstanding as of March 31, 2026 | 14912962 | $1.04 | $3716511 | 9.20 |

---

The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company's shares of common stock for those options that had exercise prices lower than the fair value of the Company's shares of common stock.

The weighted-average grant date fair value of options granted was $1.04 and $0.42 for the years ended March 31, 2026 and 2025, respectively.

As of March 31, 2026 and 2025, the total remaining unrecognized compensation expense related to non-vested stock options was $4,672 and $308, respectively, which will be amortized over the weighted-average period of 3.37 years and 0.94 years, respectively.

Total stock-based compensation expense for the three months ended March 31, 2026 and 2025 was as follows (in thousands):

---

| | | |
|:---|:---|:---|
|  | **Three Months Years Ended** | **Three Months Years Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| Cost of sales | 15 | 4 |
| Research and development | 33 | 36 |
| Sales and marketing | 7 | 16 |
| General and administrative | 148 | 26 |
| Total stock-based compensation expense | 203 | 82 |

---

**Note 10 – Income Taxes**

The Company's quarterly tax provision and estimate of its annual effective tax rate is subject to variation due to several factors, including variability in pre-tax income (or loss), the mix of jurisdictions to which such income (or loss) relates, changes in how the Company does business, and tax law developments. The Company's estimated effective tax rate for the year differs from the U.S. statutory rate of 21% primarily as a result of not benefiting U.S. losses as those losses are not more likely than not to be realized, as well as its foreign operations, which are subject to tax rates that differ from those in the United States.

The Company recorded an income tax expense of $36 and $0 for the three months ended March 31, 2026 and 2025, respectively.

**Note 11 – Commitments and Contingencies**

In August 2018, The Israeli subsidiary entered into a lease agreement for a 60-month period beginning January 1, 2019. The subsidiary may terminate the lease agreement on December 31 of each year with 6-month advance written notice to the lessor. If the subsidiary to terminate the lease agreement at the first 48-month period, then an exit penalty of $241 will apply.

In May 2021, the lease agreement was amended where Subsidiary and lessor agreed to convert fifty percent from February-December 2021 monthly rent payments into fully vested warrants to purchase 56,325 shares of the Company's common stock issuable upon exercise of this warrant and exercise price of 0.0001$ per share. The warrants will expire on April 30, 2026.

In August 2021, the lease agreement was further amended where the Subsidiary and lessor agreed to convert fifty percent from 2022 monthly rent payments into a warrants to purchase 63,015 shares of the Company's common stock issuable upon exercise of this warrant and exercise price of 0.0001$ per share. The warrants will expire on September 30, 2026.

On August 22, 2024 the warrants were exercised by the lessor and accordingly, 119,340 common Stock were issued.

In July 2022, the Israeli Subsidiary gave the lessor advanced notice of its intention to exercise the exit point on December 31, 2022, while negotiating the fifth-year terms. The parties were unable to reach agreements and in July 2023 the subsidiary vacated the leased premises. In February 2025 a lawsuit was filed against the Company for a total of $1,600. Given the preliminary stage in which the lawsuit is at, the Israeli Subsidiary lawyers cannot reasonably assess the likelihood of the claims to be accepted. The company accounted for $1,600 and the amount is included in Accrued and other current liabilities.

**Note 12 – Subsequent Events**

On April 9, 2026, the Securities and Exchange Commission declared effective the registration statement covering the resale of shares issuable under the Company's equity line financing arrangement originally entered into on October 27, 2025 pursuant to a Securities Purchase Agreement. The facility provides the Company with the right, but not the obligation, to direct the purchaser to purchase shares of the Company's common stock from time to time, subject to specified pricing, volume and other customary conditions, for aggregate gross proceeds of up to $300.0 million. Following the effectiveness of the registration statement, the Company became eligible to access the facility in accordance with its terms. In April and May 2026, the Company entered into amendments to the equity line financing arrangement that modified certain operational, pricing and settlement provisions and reduced the maximum aggregate purchase commitment under the facility from $300.0 million to $50.0 million.

On May 4, 2026, the Company issued a Second Promissory Note in the principal amount of $1,000,000. The Second Promissory Note bears interest at a rate of 10% per annum and matures on September 1, 2026. The Company is required to apply a cumulative total 25% of the net proceeds from any future offerings or issuances of the Company's securities toward repayment of the Second Promissory Note and/or the Promissory Note issued March 1, 2026 until both notes are paid in full. In the event of default, the Second Promissory Note will bear interest at a rate of 24% per annum, and any late payments will be subject to a late fee equal to 10% of the overdue amount.

Also on May 4, 2026, the Company entered into amendments to certain warrants originally issued in connection with the Company's October 27, 2025 Series D financing transactions. Pursuant to the amendments, warrants to purchase an aggregate of 9,000,000 shares of common stock were repriced, including (i) three tranches of 1,000,000 warrants each expiring February 27, 2027 repriced to exercise prices of $1.25, $1.75 and $2.25 per share, respectively, and (ii) three tranches of 2,000,000 warrants each expiring October 27, 2027 repriced to exercise prices of $3.50, $4.00 and $4.50 per share, respectively. In addition, all remaining 15,991,902 Series D warrants, as well as 300,000 Series C warrants, were cancelled.

Further, on May 4, 2026, the Company agreed to amend the Certificates of Designation relating to its Series C Preferred Stock and Series D Preferred Stock. Pursuant to the amendments, the conversion price of the Series D Preferred Stock was adjusted to $2.0265 per share. In addition, a "leak-out" provision was added to both the Series C Preferred Stock and Series D Preferred Stock, pursuant to which holders collectively may not sell, on any trading day, a number of conversion shares exceeding 10% of the total daily trading volume of the Company's common stock, unless such sales are made at a price equal to or greater than 115% of the closing price of the Company's common stock on the immediately preceding trading day.

The Company has evaluated all transactions through May, 15, 2026, the date these consolidated financial statements were available to be issued and has determined that there are no other events, other than the following, that would require disclosure in or adjustment to these financial statements.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

**<u>Overview</u>**

We use third party AI tools like ChatGPT internally across the spectrum of our operations. Additionally, we have developed and continue to develop Bond AI capabilities. Bond's AI (which is currently in production) consists largely of proprietary rule-based systems that assist us in identification of potential anomalies for further review by our agents.

Bond's vision is to leverage AI to enable personal security services to be more scalable, effective and ultimately affordable for more people. The Bond Preventative Personal Security Platform is designed with that vision, allowing us to incorporate increasing amounts of AI over time as technology advances. The chart below shows some of the key areas where we have incorporated AI, their current state and future plans:

---

| | | |
|:---|:---|:---|
| **Task** | **AI currently in use by Bond** | **AI in R&D** |
| Anomaly detection | Bond-developed rule-based systems based on past data and expert input | Bond-developed machine learning models trained on past anomaly data |
| Supporting agent decision-making | Third-party AI tools for agent decision support | Implementing a RAG incorporating Bond processes and content with third-party data |
| Automated translation | Third-party AI tools for translation of services and content | Third-party tools for automated live translation of calls |
| Automating quality assurance | Automated test suites for code | Automated assessment of live agent performance |
| AI interviewing, hiring, and training agents | Video interviews and third-party AI assessment to accelerate hiring funnel | Increased use of automation and virtual agents in agent training and onboarding processes |
| Creation of content that facilitates informing end users about the Bond service and platform | Third-party AI tools for generating and optimizing marketing content, including videos and images |  |
| Automating of agent administrative tasks |  | Automated transcription, translation, and summarization of cases |
| Automatically triaging active calls to identify "hot" cases |  | Automated analysis of active calls to flag high-risk cases for supervisor attention |
| Automatically triaging incoming calls in overload situations |  | Virtual agents that gather information about situations and prioritize cases for human agents |
| Facial recognition for "bad actors" |  | Integrating third-party facial recognition technology with Bond's platform |
| Automating and optimizing customer messaging |  | Automated CRM suites that use AI to customize messaging for each customer |
| Automating drone response to reported incidents |  | Patented techniques for autonomous drone navigation and collision avoidance |

---

We offer 14 distinct services through our phone app (the "***Bond App***") and fully automated Bond Command Centers located around the world, that allow Bond members to choose when and how Bond will keep them secure while preserving their privacy.

The Bond Preventative Personal Security Platform is a multilayered, multifaceted technology platform that incorporates numerous technologies, inputs and outputs to other systems, and third-party information. It allows us to perform a large number of multi-functional activities relative to a large number of end-users/members, with a high level of precision, speed and reliability, as well as affordably, in a manner that is automated. The core functionality includes: (1) "look after" a massively scalable number of members/end-users simultaneously; at their or their guardians request, monitor them, collect data from multiple sources – on the phone of the member, from what Bond historically knows about the member; from what Bond knows about the area/location of the member, from what the member has shared with Bond – in order to detect anomalies in real time; (2) communicate with the member in order to verify their status, potentially engage Bond Personal Security Agents in order to calm, guide, deter or orchestrate help for the member; (3) record and analyze all activities in the Bond sphere, which included on the phones of the end-users, in the Command Centers and through our technology.

**Corporate Organization**

We conduct our operations through eight wholly owned subsidiaries, organized as follows:

![](form10-q_001.jpg)

● TG- 17 (Israel) Ltd. was incorporated in 2017 and provides R&D services to Our Bond, Inc. Since 2023 the subsidiary operates also as Command Center for Israel and global users (members).

● Bond Bodyguard New York, Inc., a New York corporation, was incorporated in 2020 for the sole purpose of obtaining bodyguard licenses in the US. Services are given under Our Bond, Inc. Currently, we are licensed in 11 states and submitted application for additional states.

● TG-17 (UK) Ltd. was incorporated in 2023 to provide services to UK citizens and global members.

● TG-17 France, was incorporated in 2024 to provide services to French citizens and global members.

● TG-17 Belgium, a société à responsabilité limitée, was incorporated in 2025 to provide services to Belgian citizens and global members.

● TG-17 (Canada) Inc., a corporation subject to the Business Corporations Act (Ontario), was incorporated in 2025 to provide services to Canadian citizens and global members.

● TG-17 Brazil Ltda., was incorporated in 2025 to provide services to Brazilian citizens and global members.

● TG-17 Mexico., was incorporated in 2025 to provide services to Mexican citizens and global members.

All subsidiaries are 100% controlled/owned by Our Bond, Inc.

**Components of Results of Operations**

*Net Revenues.*

The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers, which provides a five-step framework through which revenue is recognized when control of promised goods or services is transferred to a customer at an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To determine revenue recognition for arrangements that the Company concludes are within the scope of ASC 606, management performs the following five steps: (i) identifies the contract(s) with a customer; (ii) identifies the performance obligations in the contract(s); (iii) determines the transaction price, including whether there are any constraints on variable consideration; (iv) allocates the transaction price to the performance obligations; and (v) recognizes revenue when (or as) the Company satisfies a performance obligation.

The Company provides comprehensive security solutions. The company's flagship offering is a cloud-based Software-as-a-Service ("***SaaS***") that delivers a preventative personal security solution platform. Additionally, the Company offers comprehensive and customized services designed to protect its clients. These services include, but are not limited to, on/off premise guards, assets protection, threat assessment and monitoring and other tailored-made security services. Revenue is recognized either over time or at a point in time, depending on the nature of each customer's agreement. For its subscription-based SaaS solution delivered through the Company's platform, revenue is typically recognized over time as services are made available on an on-going basis. In contrast, for performance obligations of services described above other than the SaaS solution, we generally satisfy our obligations *vis-à-vis* each deliverable as it occurs and is provided to the customer. The customers simultaneously receives and avails the benefits of our services, at which point these performance obligations are deemed to be satisfied.

We group the above services offerings into one broad category which generates all of Company's revenue through, primarily, the following sales:

● B2B (or B2G): selling to private or public institutions who use the services in order to protect their people (employees, students, residents, etc.).

● B2B2C: selling to or through corporations so they can sell/subsidize/gift Bond services to their own consumers.

● DTC: selling directly to consumers.

The Company combines and accounts for multiple contracts as a single contract when they are negotiated together with the same customer at or near the same time in order to achieve a single commercial objective, or when the contracts are related in other ways.

Transaction price may be comprised of fixed consideration and variable consideration. The Company's contracts are typically for fixed consideration.

For all contracts with customers that have more than one performance obligation, the Company allocates the transaction price to each separate performance obligation based on the relative SSP of each performance obligation. The SSP is typically the price at which the Company sells service separately to a customer. The best evidence of an SSP, if available, is the observable price charged in similar circumstances and to similar customers. If an SSP is not directly observable, the Company estimates SSP using various observable inputs including historical internal pricing data and cost-plus expected margin analysis due to the limited standalone sales history.

For the three months ended March 31, 2026, the Company demonstrated annual recurring revenue ("ARR") of approximately $10 million and total bookings of $10.5 million. For the three months ended March 31, 2025, the Company demonstrated ARR of approximately $9.74 million and total bookings of $10.6 million. The Company use ARR as a metric to measure customer demand and growth, and use booking values act as an indicator of customer engagement, including new sales and renewals. These figures highlight consistent growth and increasing customer demand.

Total bookings represent the aggregate dollar value of all customer contracts executed during a given period, inclusive of both recurring subscription and service commitments and any associated one-time fees (e.g., implementation, setup or training). Bookings are expressed based on the total committed contract value, regardless of the timing of invoicing or revenue recognition under U.S. GAAP. We calculate ARR using a trailing actuals method to provide a conservative measure of recurring revenue. Specifically, we determine average Monthly Recurring Revenue ("***MRR***") based on actual recurring revenue recognized over the prior 12 months and multiply that amount by 12 to derive ARR. This method smooths short-term fluctuations and reflects actual earned recurring revenue rather than forward-looking projections. ARR excludes one-time fees, usage-based overages, and non-recurring revenues. No adjustments are made for potential future churn, upgrades, or downgrades beyond the actual results in the trailing period.

*Cost of Services Sold.*

Cost of Services sold primarily consists of our Command Center operations and other rendered services that we outsource to third-party for particular security services offering. As a subscription-based business, our model emphasizes scalability so that most costs do not increase linearly with revenue growth.

*Operating Expenses*.

Operating expenses consist of general and administrative expenses, which are primarily salaries, professional fees, and expenses related to the administrative functions of the Company, research and development expenses, which consist primarily of product development costs and salaries, and sales and marketing expenses, which represent advertising and direct marketing costs, as well as the associated personnel costs.

**Results of Operations**

***Comparison of the three months ended March 31, 2026 to the three months ended March 31, 2025***

*Net Revenues*

The majority of our net revenues for the three months ended March 31, 2026 and 2025, were generated from our B2B services. For the three months ended March 31, 2026, 15.47% of our revenue was generated from cloud-based SaaS services, while 84.53% came from our physical service offerings. This compares to 14.67% and 85.33%, respectively, for the three months ended March 31, 2025.

Total revenue increased by $98,000 or approximately 4.36% to $2,347,000 for the three months ended March 31, 2026, compared to approximately $2,249 for the three months ended March 31, 2025. This increase reflects continued demand for our security services and modest growth in our customer base during the three months ended March 31, 2026 compared to the same period in 2025

*Cost of Services Sold.*

Our cost of services sold increased slightly by $124,000 or approximately 5.7% to $2,300,000 for the three months ended March 31, 2026 compared to $2,176,000 for the three months ended March 31, 2025. This modest change is not considered significant and primarily reflects the Company's continued global expansion and the use of outsourced services to support its growth initiatives.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | *($ in thousands)* | *($ in thousands)* |
| Command Center Operations | $853 | $581 |
| Security Services | 1447 | 1595 |
|  | $2300 | $2176 |

---

*Operating Expenses.*

Our operating expenses for the three months ended March 31, 2026 and 2025 were as follows:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | *($ in thousands)* | *($ in thousands)* |
| General and Administrative | $2441 | $1026 |
| Research and Development | 691 | 555 |
| Sales and Marketing | 3290 | 277 |
|  | $6422 | $1858 |

---

Our operating expenses for the three months ended March 31, 2026, were approximately $6,422,000 compared to approximately $1,858,000 for the three months ended March 31, 2025, an increase of approximately $4,564,000.

The increase in operating expenses for the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, was primarily attributable to non-recurring costs associated with the Company's transition to and operation as a public company following the completion of its public listing on February 4, 2026. Such costs included approximately $1.2 million of one-time expenses related to the public listing transaction, a $2.0 million strategic marketing investment related to 2026 (TV ads that will be aired in the second half of 2026), approximately $0.8 million of investor relations expenses, and approximately $0.4 million of incremental public company operating costs, primarily consisting of increased directors and officers insurance premiums and accounting-related expenses.

*Net Profit/Loss*

As a result of the foregoing, the Company suffered a net loss of approximately $6,703,000 for the three months ended March 31, 2026, compared to a net loss of approximately $2,162,000 for the three months ended March 31, 2025.

**Liquidity and Capital Resources**

*Overview*

Since inception, we have funded our operations primarily through proceeds from sales of our capital stock and, to a lesser extent, cash flow generated from operating activities. Based on our current operating plan, we believe that our existing cash and cash equivalents, together with anticipated cash generated from operations, will support our working capital and capital expenditure requirements for the near term.

Our future capital requirements will depend on many factors, including the pace of growth in our customer base, the timing and extent of investments in our platform and services, expansion of our sales and marketing activities, and general economic conditions. To support our operations and growth initiatives, the Company expects to obtain additional capital through equity financing and other financing instruments that have been arranged or are available to the Company.

In alignment with Bond's business plan and operating model, management projects that as sales and the number of end-users increase, utilization of the overall Bond platform will improve, driving the company toward profitability.

When referring to the Bond platform, we include the full ecosystem that enables and supports the service globally, including: command centers around the world; security agents; engineering resources responsible for developing, maintaining, and enhancing the technology that powers the app, command centers, and cloud infrastructure; as well as the company's relationships with third parties, first responders, and other key partners.

At this stage, the Bond platform has been built to scale and support a significant global end-user base. We continue to gradually onboard additional end-users as we secure new customers and as existing corporate customers expand the population of employees offered the Bond service. At the same time, we are steadily increasing our investments in marketing and sales in order to accelerate growth and advance the company toward profitability.

*Summary of Cash Flows*

The following table summarizes our cash flows for the three months ended March 31, 2026 and 2025.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | *($ in thousands)* | *($ in thousands)* |
| Net cash (used in) operating activities | $(4410) | $(1416) |
| Net cash (used in) investing activities | (11) |  |
| Net cash provided by financing activities | 7607 | 2127 |
| Effect of exchange rate changes on cash | (27) | (17) |
| Cash and cash equivalents at end of period | $3758 | $1420 |

---

*Operating Activities.*

We continue to experience negative cash flow from operating activities as we expand our business. Cash flows from operating activities are significantly affected by investments to support the growth of our business, including expenditures related to product and service development, engineering resources required to maintain and enhance our technology platform, Command Center operations, and selling, general and administrative functions. In addition, operating cash flows during the three months ended March 31, 2026 were adversely affected by non-recurring costs associated with the Company's transition to and operation as a public company following the completion of its public listing on February 4, 2026. Such costs included approximately $1.2 million of one-time expenses related to the public listing transaction, a $2.0 million strategic marketing investment related to 2026 (TV ads that will be aired in the second half of 2026), approximately $0.8 million of investor relations expenses, and approximately $0.4 million of incremental public company operating costs, primarily consisting of increased directors and officers insurance premiums and accounting-related expenses. Operating cash flow also continue to be impacted by working capital requirements associated with supporting our growth, including fluctuations in personnel-related expenditures, accounts payable, and other current assets and liabilities.

Net cash used in operating activities for the three months ended March 31, 2026 was approximately $4,410,000 which reflects our net loss of approximately $6,703,000. Net cash used in operating activities for the three months ended March 31, 2025 was approximately $1,416,000 which reflects our net loss of approximately $2,162,000.

*Investing Activities*

Our investing activities have consisted primarily of the purchases of assets and equipment. We have invested in assets and equipment to support our Command Center growth.

Net cash used in investing activities for the three months ended March 31, 2026 was approximately $11,000 which was entirely attributable to purchases of IT and other Electronic equipment.

 

*Financing Activities*

Net cash provided by financing activities was $7.6 million during the three months ended March 31, 2026, consisting primarily of $2.95 million in proceeds from the issuance of Series D convertible preferred stock, $2.5 million in proceeds from the issuance of a promissory note, and $3.5 million from the exercise of common warrants, partially offset by repayments of related party loans, promissory note and stock issuance costs.

**Issuance of Series D Preferred Stock**

On October 27, 2025, the Company entered into a Securities Purchase Agreement (the "SPA") for the issuance and sale of up to 549,451 shares of Series D Preferred Stock. During 2025, the Company completed four closings under the SPA and issued an aggregate of 225,275 shares of Series D Preferred Stock for gross proceeds of approximately $2.1 million. During the three months ended March 31, 2026, the Company completed the remaining closings under the SPA and issued an additional 324,176 shares of Series D Preferred Stock for aggregate gross proceeds of approximately $2.95 million. Issuance costs incurred during the three months ended March 31, 2026 were approximately $0.2 million.

**Exercise of Series C and Series D Common Warrants**

During February 2026, holders of the Company's Series C and Series D warrants exercised warrants to purchase an aggregate of 1,041,433 shares of the Company's common stock. The Series C warrants were exercised at an exercise price of $3.2475 per share, and the Series D warrants were exercised at an exercise price of $12.35 per share. As a result of these exercises, the Company received aggregate gross proceeds of approximately $3.46 million.

**Promissory Note**

On March 1, 2026, the Company issued a Promissory Note in the principal amount of $2,500,000. The Promissory Note bears interest at a rate of 10% per annum and matures on September 1, 2026. The Company is required to apply 25% of the net proceeds from any future offerings or issuances of the Company's securities toward repayment of the Promissory Note until it is paid in full. In the event of default, the Promissory Note will bear interest at a rate of 24% per annum, and any late payments will be subject to a late fee equal to 10% of the overdue amount.

The following table summarizes our financing activities for the three months ended March 31, 2026 and 2025.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | *($ in thousands)* | *($ in thousands)* |
| Payments as part of Related Party Loans | $(555) | $(350) |
| Issuance of Series CF Preferred Stock |  | 2535 |
| Issuance of Series CF Preferred Stock fundraising fees |  | (58) |
| Issuance of Series D convertible preferred stock | 2950 |  |
| Issuance of Series D convertible preferred stock - issuance costs | (271) |  |
| Issuance of Promissory Note | 3000 |  |
| Payment of Promissory Note | (500) |  |
| Exercise of Series C Common Warrants | 3356 |  |
| Exercise of Series C Common Warrants - issuance costs | (235) |  |
| Exercise of Series D Common Warrants | 100 |  |
| Exercise of Series D Common Warrants - - issuance costs | (7) |  |
| Exercise of Common Stock Warrants | 19 |  |
| Direct Listing Costs | (250) | - |
|  | $7607 | $2127 |

---

**Off-Balance Sheet Arrangements**

We did not have during the periods presented, and we do not currently have, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

**Critical Accounting Policies and Estimates**

Management's discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements and the related notes thereto, which have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). In preparing the condensed consolidated financial statements, we apply accounting policies and estimates that affect the reported amounts and related disclosures. Inherent in such policies are certain key assumptions and estimates made by management, which we believe best reflect our underlying business and economic conditions. Our estimates are based on historical experience and various other factors and assumptions that we believe are reasonable under the circumstances. We regularly re-evaluate our estimates used in the preparation of the condensed consolidated financial statements based on our latest assessment of the current and projected business and economic environment. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty and actual results could differ materially from the amounts reported based on these estimates. There have been no material changes to our critical accounting policies and estimates as described in Item 7 of Part II, "Management's Discussion and Analysis of Financial Condition and Results of Operations" of our 2025 Annual Report on Form 10-K.

**Recently Accounting Pronouncements and SEC Rules**

See Note 1 to our Consolidated Financial Statements included elsewhere in this Form 10-Q for recently adopted accounting pronouncements and SEC rules and recently issued accounting pronouncements not yet adopted as of the date of this report.

**Contractual Obligations and Commitments**

In addition to ongoing capital expenditures and working capital needs to fund operations over the next twelve (12) months, our contractual obligations to make future payments primarily relate to our operating lease obligations and insurance obligations, all of which are governed by agreements with month-to-month terms, and which are generally terminable after a notice period at any time. We purchase equipment and software necessary to conduct our operations on an as-needed basis.

**Known Trends, Events and Uncertainties**

We are not currently aware of any trends, events, or uncertainties that are reasonably likely to have a material effect on our financial condition. For a further discussion of factors that may affect future operating results, see the section entitled "Risk Factors" in our most recent annual report on Form 10-K.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

We are a smaller reporting company as defined by Rule 229.10(f)(1) and are not required to provide information under this item.

**Item 4. Controls and Procedures.**

**Evaluation of Disclosure Controls and Procedures**

The Company's management, with the participation of the Company's Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of March 31, 2026. Based on that evaluation, the Company's Chief Executive Officer and the Company's Chief Financial Officer have concluded that as of the period ended March 31, 2026, the Company's disclosure controls and procedures were effective.

As described in our Annual Report on Form 10-K for the year ended December 31, 2025, under the supervision and with the participation of management, including the Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in "Internal Control — Integrated Framework (2013)" issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on the results of this evaluation, our senior management has concluded that the Company's internal controls over financial reporting were effective for the period ended December 31, 2025.

**Changes in Internal Control Over Financial Reporting** 

There were no changes in our internal control over financial reporting identified in management's evaluation pursuant to Rules 13a-15(d) or 15d-15(d) of the Exchange Act during the quarter ended March 31, 2026, that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Limitations on Effectiveness of Controls and Procedures**

In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures and internal control over financial reporting must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs.

**PART II - OTHER INFORMATION**

**Item 1. Legal Proceedings.**

In July 2022, the Israeli Subsidiary gave the lessor advanced notice of its intention to exercise the exit point on December 31, 2022, while negotiating the fifth-year terms. The parties were unable to reach agreements and in July 2023 the subsidiary vacated the leased premises. In February 2025 a lawsuit was filed against the Company for a total of $1,600. Given the preliminary stage in which the lawsuit is at, the Israeli Subsidiary's lawyers cannot reasonably assess the likelihood of the claims to be accepted by court. Given that Company's plan to litigate the case, and given the dynamics of such trials in Israel, a decision by a court is not anticipated until 2027.

From time to time, we may be party to litigation arising in the ordinary course of business. Except as described above, as of the date of this prospectus, we are not subject to any material legal proceedings nor, to the best of our knowledge, are any material legal proceedings pending or threatened against us.

**Item 1A. Risk Factors.**

Our business, financial condition, operating results, and cash flows may be impacted by a number of factors, many of which are beyond our control, including those set forth in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (the "SEC") on March 31, 2026, the occurrence of any one of which could have a material adverse effect on our actual results.

There have been no material changes to our risk factors previously disclosed in Item 1A. of Part I, "Risk Factors" of our 2025 Annual Report on Form 10-K, filed March 31, 2026.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

There were no sales of equity securities during the period covered by this Quarterly Report that were not registered under the Securities Act or were not previously reported in a Current Report on Form 8-K filed by the Company.

**Item 3. Defaults Upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not applicable.

**Item 5. Other Information.**

None.

**Item 6. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 31.1+ | [Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-1.htm) |
| 32.1\* | [Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-1.htm) |
| 31.2\*\* | [Certification of Principal Financial and Accounting Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex31-2.htm) |
| 32.2\*\* | [Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex32-2.htm) |
| 101.INS | Inline XBRL Instance Document |
| 101.SCH | Inline XBRL Taxonomy Extension Schema |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

\* Filed herewith. <br> \*\* Furnished herewith.

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| DATE: May 15, 2026 | **Our Bond, Inc.** | **Our Bond, Inc.** |
|  | By: | */s/ Doron Kempel* |
|  |  | Doron Kempel |
|  |  | Chief Executive Officer |
|  |  | (Principal Executive Officer) |
|  | By: | */s/ Amit Hod* |
|  |  | Amit Hod |
|  |  | Chief Financial Officer |
|  |  | (Principal Financial Officer |
|  |  | Principal Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION PURSUANT TO**

**RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO**

**SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Doron Kempel, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 of Our Bond, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the quarter end covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the quarter end presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the quarter end in which this report is being prepared;

(b) Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the quarter end covered by this report based on such
 evaluation; and

(d) Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;(a) All
 significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
 reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information;
 and

(b) Any
 fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
 internal control over financial reporting.

---

| |
|:---|
| Date: May 15, 2026 |
| */s/ Doron Kempel* |
| Doron Kempel |
| Chief Executive Officer, Chairman, and President |
| (Principal Executive Officer) |

---

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION PURSUANT TO<br> RULE 13a-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,<br> AS ADOPTED PURSUANT TO<br> SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Amit Hod, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 of Our Bond, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the quarter end covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the quarter end presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed
 such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
 to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
 within those entities, particularly during the quarter end in which this report is being prepared;

(b) Designed
 such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
 supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
 for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated
 the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
 the effectiveness of the disclosure controls and procedures, as of the end of the quarter end covered by this report based on such
 evaluation; and

(d) Disclosed
 in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
 most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
 or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| Date: May 15, 2026 |
| */s/ Amit Hod* |
| Amit Hod |
| Chief Financial Officer |
| (Principal Financial and Accounting Officer) |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Our Bond, Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Doron Kempel, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended,

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| Dated: May 15, 2026 |
| */s/ Doron Kempel* |
| Doron Kempel |
| Chief Executive Officer, Chairman, and President |
| (Principal Executive Officer) |

---

## Exhibit 32.2

**Exhibit 32.2**

**CERTIFICATION PURSUANT TO**

**18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Our Bond, Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2026, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Amit Hod, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| Dated: May 15, 2026 |
| */s/ Amit Hod* |
| Amit Hod |
| Chief Financial Officer |
| (Principal Financial and Accounting Officer) |

---